Home » Topics » Regulatory » Patents

Patents
RSS

NK1 antagonists from Glaxo Wellcome

Sep. 13, 1996

Meiji Seika discloses natural progesterone antagonists

Sep. 6, 1996

AGE-specific monoclonal antibody from Alteon

Sep. 6, 1996

Terumo pursues treatments for diabetes and complications

Sep. 6, 1996

Trypsin inhibitors for pancreatitis

Sep. 6, 1996

Monoclonal antibody for thrombotic disorders from Teijin

Sep. 6, 1996

Bayer's new cGMP PDE inhibitors

Sep. 6, 1996

Hisamitsu describes platelet aggregation inhibitors

Sep. 6, 1996

E. Merck describes cardioactive agents

Sep. 6, 1996

Genentech claims CHF for heart failure and neurological disorders

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...